"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis

Abstract

Infection is a common complication of cystic fibrosis (CF) airway disease. Current treatment approaches include early intervention with the intent to eradicate pathogens in the hope of delaying the development of chronic infection and the chronic use of aerosolized antibiotics to suppress infection. The use of molecules that help restore CFTR (cystic fibrosis transmembrane conductance regulator) function, modulate pulmonary inflammation, or improve pulmonary clearance may also influence the microbial communities in the airways. As the pipeline of these new entities continues to expand, it is important to define when key pathogens are eradicated from the lungs of CF patients and, equally important, when new pathogens might emerge as a result of these novel therapies.

Keywords: Mycobacterium abscessus; Pseudomonas aeruginosa; Staphylococcus aureus; chronic infection; cystic fibrosis; emerging pathogen; eradication.